ProQR's leadership is a strong team with proven track record. Find out who is on our management team, board of directors and scientific advisory board.
On behalf of all ProQRians, happy Rare Disease Day 2022. Both within ProQR and outside, we join the community in raising awareness and trying to generate change for people worldwide living with a rare disease, their families, and supporters.
… ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer LEIDEN, the Netherlands, March … Strategy Officer. Dr. Rodman has had a long career in drugdevelopment including leadership roles in translational …
… held on April 8 - 10 in Monte Carlo, Monaco. World Orphan Drug Congress USA On Thursday, April 26, 2018 at 5:20 pm ET, … companies are ramping up innovation to boost orphan drugdevelopment and patient centricity’ during the World …
LEIDEN, Netherlands & CAMBRIDGE, Mass., July 21, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced the strengthening of the Company’s
